Investcorp leads a $17.5m investment in V-Ensure

In a $17.5 million deal, Investcorp, a renowned worldwide alternative investment group, announced its investment in V-Ensure Pharma Technologies (V-Ensure).

Investcorp led the round, with Tanas Capital, a private investment firm based in Asia, also participating. This is Investcorp’s third healthcare venture in India and the company’s first in the pharmaceutical industry.

V-goal Ensure’s with this financing is to pursue growth prospects in North America, Europe, and other global markets for product development and launch.

The investment also reaffirms Investcorp’s commitment to invest in India’s industry-leading business services, information technology, and healthcare industries to help them expand and gain a competitive edge in the global market.

V-Ensure was founded in 2010 and is a prominent creator of speciality pharmaceutical formulations for regulated markets, with a focus on complex generics. The company’s core competency is the development of complex molecules for regulated markets while avoiding patent infringement.